PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2017 | 16 | 1 |
Tytuł artykułu

Edible mushroom Pleurotus ostreatus (Oyster mushroom) - its dietary significance and biological activity

Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Pleurotus ostreatus (Jacq.) P. Kumm. (Basidiomycota) – known as the oyster mushroom – is a mushroom species distributed on all continents, except for Antarctica. Since World War I it has been commercially cultivated on a large scale. Pleurotus ostreatus is a valuable mushroom of dietary importance. It is rich in primary and secondary metabolites and chemical elements of physiological significance. One hundred grams of fresh fruiting bodies contains 15% of the recommended daily intake of vitamin C, 40% of niacin, riboflavin, and thiamin, and 0.5 mg of vitamin B12. This species is also characterized by a high content of oleic acid (40%), linolenic acid (55%), and substances responsible for decreasing serum cholesterol levels. High contents of lovastatin, an approved hypolipidemic drug, and pleuran, an immunomodulating polysaccharide, have been found in fruiting bodies of this species. It exhibits antiatherosclerotic, hypoglycemic, antioxidant, anticancer and immunomodulatory properties. Due to its wide spectrum of biological activities, P. ostreatus is considered a medicinal mushroom. Fruiting bodies and extracts of P. ostreatus have found applications in the treatment of civilization – related diseases, especially diabetes, arteriosclerosis and cancer. It is also a potential source of active ingredients in cosmetics and topically applied preparations. Key
Słowa kluczowe
EN
Wydawca
-
Rocznik
Tom
16
Numer
1
Opis fizyczny
p.151-161,fig.,ref.
Twórcy
autor
  • Medical College in Krakow, Jagiellonian University, Krakow, Poland
  • Medical College in Krakow, Jagiellonian University, Krakow, Poland
autor
  • Medical College in Krakow, Jagiellonian University, Krakow, Poland
Bibliografia
  • Abrams, D.I., Couey, P., Shade, S.B., Kelly, M.E, Kamanu-Elias, N., Stamets, P. (2011). Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy. BMC Complement. Altern. Med., 11, 60.
  • Ahmad, N., Mahmood, F., Khalil, S.A., Zamir, R., Fazal, H., Abbasi, B.H. (2014). Antioxidant activity via DPPH, gram-positive and gram-negative antimicrobial potential in edible mushrooms. Toxic. Ind. Health., 30, 826–834.
  • Alam, N., Amin, R., Khan, A., Ara, I., Shim, M.J., Lee, M.W., Lee, U.Y., Lee, T.S. (2009). Comparative effects of oyster mushrooms on lipid profile, liver and kidney function in hypercholesterolemic rats. Mycobiology, 37, 37–42.
  • Alam, N., Yoon, K.N., Lee, K.R., Shin, P.G., Cheong, J.C., Yoo, Y.B., Shim, J.M., Lee, M.W., Lee, U.Y., Lee, T.S. (2010). Antioxidant activities and tyrosinase inhibitory effects of different extracts from Pleurotus ostreatus fruiting bodies. Mycobiology, 38, 295–301.
  • Anandhi, R., Annadurai, T., Anitha, T.S., Muralidharan, A.R., Najmunnisha, K., Nachiappan, V., Thomas, P.A., Geraldine, P. (2013). Antihypercholesterolemic and an tioxidative effects of an extract of the oyster mushroom, Pleurotus ostreatus, and its major constituent, chrysin, in Triton WR-1339-induced hypercholesterolemic rats. J. Physiol. Biochem., 69, 313–323.
  • Arbaayah, H.H., Kalsom, Y.U.Abrams, D.I., Couey, P., Shade, S.B., Kelly, M.E, Kamanu-Elias, N., Stamets, P. (2011). Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy. BMC Complement. Altern. Med., 11, 60.
  • Ahmad, N., Mahmood, F., Khalil, S.A., Zamir, R., Fazal, H., Abbasi, B.H. (2014). Antioxidant activity via DPPH, gram-positive and gram-negative antimicrobial potential in edible mushrooms. Toxic. Ind. Health., 30, 826–834.
  • Alam, N., Amin, R., Khan, A., Ara, I., Shim, M.J., Lee, M.W., Lee, U.Y., Lee, T.S. (2009). Comparative effects of oyster mushrooms on lipid profile, liver and kidney function in hypercholesterolemic rats. Mycobiology, 37, 37–42.
  • Alam, N., Yoon, K.N., Lee, K.R., Shin, P.G., Cheong, J.C., Yoo, Y.B., Shim, J.M., Lee, M.W., Lee, U.Y., Lee, T.S. (2010). Antioxidant activities and tyrosinase inhibitory effects of different extracts from Pleurotus ostreatus fruiting bodies. Mycobiology, 38, 295–301.
  • Anandhi, R., Annadurai, T., Anitha, T.S., Muralidharan, A.R., Najmunnisha, K., Nachiappan, V., Thomas, P.A., Geraldine, P. (2013). Antihypercholesterolemic and an tioxidative effects of an extract of the oyster mushroom, Pleurotus ostreatus, and its major constituent, chrysin, in Triton WR-1339-induced hypercholesterolemic rats. J. Physiol. Biochem., 69, 313–323.
  • Arbaayah, H.H., Kalsom, Y.U. (2013). Antioxidant properties in the oyster mushrooms (Pleurotus spp.) and split gill mushroom (Schizophyllum commune) ethanolic extracts. Mycosphere, 4, 661–673.
  • Arora, S., Tandon, S. (2015). Mushroom extracts induce human colon cancer cell (COLO-205) death by triggering the mitochondrial apoptosis pathway and Go/G1-Phase cell cycle arrest. Arch. Iran. Med., 18, 284–295.
  • Barros, L., Baptista, P., Correia, D.M., Casal, S., Oliveira, B., Ferreira, I.C.F.R. (2007). Fatty acid and sugar compositions, and nutritional value of five wild edible mushrooms from Northeast Portugal. Food Chem., 105, 140–145.
  • Beltran-Garcia, M.J., Estarron-Espinosa, M., Ogura T. (1997). Volatile compounds secreted by the oyster mushroom (Pleurotus ostreatus) and their antibacterial activities. J. Agric. Food Chem., 45, 4049–4052.
  • Bobek, P., Galbavý, S. (1999). Hypocholesterolemic and antiatherogenic effect of oyster mushroom (Pleurotus ostreatus) in rabbits. Nahrung, 43, 339–342.
  • Bobek, P., Hromadová, M., Ozdín, L. (1995). Oyster mushroom (Pleurotus ostreatus) reduces the activity of 3-hydroxy-3-methylglutaryl CoA reductase in rat liver microsomes. Experientia, 51, 589–591.
  • Bobek, P., Ozdín, L., Galbavý, S. (1998). Dose- and timedependent hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in rats. Nutrition, 14, 282– 286.
  • Bobek, P., Ozdín, L., Kuniak, L. (1996). Effect of oyster mushroom (Pleurotus ostreatus) and its ethanolic extract in diet on absorption and turnover of cholesterol in hypercholesterolemic rat. Nahrung, 40, 222–224.
  • Cao, X.Y., Liu, J.L., Yang, W., Hou, X., Li, Q.J. (2015). Antitumor activity of polysaccharide extracted from Pleurotus ostreatus mycelia against gastric cancer in vitro and in vivo. Mol. Med. Rep., 12, 2383–2389.
  • Caz, V., Gil-Ramírez, A., Largo, C., Tabernero, M., Santamaría, M., Martín-Hernández, R., Marín, F.R., Reglero, G., Soler-Rivas, C. (2015). Modulation of cholesterol-related gene expression by dietary fiber fractions from edible mushrooms. J. Agric. Food. Chem., 63, 7371–7380.
  • Cheah, I.K., Halliwell, B. (2012). Ergothioneine; antioxidant potential, physiological function and role in disease. Biochim. Biophys. Acta. Mol. Basis Dis., 1822, 784–793.
  • Chorváthová, V., Bobek, P., Ginter, E., Klvanová, J. (1993). Effect of the oyster fungus on glycaemia and cholesterolaemia in rats with insulin-dependent diabetes. Physiol. Res., 42, 175–179.
  • Choudhury, M.B.K., Rahman, T., Kakon, A.J., Hoque, N., Akhtaruzzaman, M., Begum, M.M., Choudhuri, M.S.K., Hossain, M.S. (2013). Effects of Pleurotus ostreatus on blood pressure and glycemic status of hypertensive diabetic male volunteers Bangladesh. J. Med. Biochem., 6, 5–10.
  • Chowdhury, M.M.H., Kubra, K., Ahmed, S.R. (2015). Screening of antimicrobial, antioxidant properties and bioactive compounds of some edible mushrooms cultivated in Bangladesh. Ann. Clin. Microbiol. Antimicrob., 14, 8–13.
  • Devi, K.S., Behera, B., Mishra, D., Maiti, T.K. (2015). Immune augmentation and Dalton’s Lymphoma tumor inhibition by glucans/glycans isolated from the mycelia and fruit body of Pleurotus ostreatus. Int. Immunopharmacol., 25, 207–217.
  • Devi, K.S., Roy, B., Patra, P., Sahoo, B., Islam, S.S., Maiti, T.K. (2013). Characterization and lectin microarray of an immunomodulatory heteroglucan from Pleurotus ostreatus mycelia. Carbohydr. Polym., 94, 857–865.
  • Elbatrawy, E.N., Ghonimy, E.A., Alassar, M.M., Wu, F.S. (2015). Medicinal mushroom extracts possess differential antioxidant activity and cytotoxicity to cancer cells. Int. J. Med. Mushrooms, 17, 471–479.
  • El-Fakharany, E.M., Haroun, B.M., Ng, T.B., Redwan, E.R. (2010). Oyster mushroom laccase inhibits hepatitis C virus entry into peripheral blood cells and hepatoma cells. Prot. Pept. Lett., 17, 1031–1039.
  • Fričová, O., Koval’aková, M. (2013). Solid-State 13C CP MAS NMR spectroscopy as a tool for detection of (1→3, 1→6)-β-D-Glucan in products prepared from Pleurotus ostreatus. ISRN Anal. Chem., vol. 2013, Artic. ID 248164, 4 p.
  • Gąsecka, M., Mleczek, M., Siwulski, M., Niedzielski, P. (2015). Phenolic composition and antioxidant properties of Pleurotus ostreatus and Pleurotus eryngii enriched with selenium and zinc. Eur. Food Res. Technol., 226, 737–743.
  • Gunde-Cimerman, N., Cimerman, A. (1995). Pleurotus fruiting bodies contain the inhibitor of 3-hydroxy-3 methylglutaryl-coenzyme a reductase-lovastatin. Exp. Mycol., 19, 1–6.
  • Hajhashemi, V., Vaseghi, G., Pourfarzam, M., Abdollahi, A. (2010). Are antioxidants helpful for disease prevention? Res. Pharm. Sci., 5, 1–8.
  • Jayakumar, T., Sakthivel, M., Thomas, P.A., Geraldine, P. (2006). Antioxidant activity of the oyster mushroom Pleurotus ostreatus, on CCl(4)-induced liver injury in rats. Food Chem. Toxic., 44, 1989–1996.
  • Jayakumar, T., Thomas, P.A., Isai, M., Geraldine, P. (2008). Pleurotus ostreatus, an oyster mushroom, decreases the oxidative stress induced by carbon tetrachloride in rat kidneys, heart and brain. Chem. Biol. Interact., 176, 108–120.
  • Jayakumar, T., Thomas, P.A., Isai, M., Geraldine, P. (2010). An extract of the oyster mushroom, Pleurotus ostreatus, increases catalase gene expression and reduces protein oxidation during aging in rats. Chin. J. Integr. Med., 8, 774–780.
  • Jayasuriya, W.J., Suresh, T.S., Abeytunga, D., Fernando, G.H., Wanigatunga, C.A. (2012). Oral hypoglycemic activity of culinary-medicinal mushrooms Pleurotus ostreatus and P. cystidiosus (higher basidiomycetes) in normal and alloxan-induced diabetic Wistar rats. Int. J. Med. Mushrooms, 14, 347–355.
  • Jayasuriya, W.J., Wanigatunge, C.A., Fernando, G.H., Abeytunga, D.T., Suresh, T.S. (2015). Hypoglycaemic activity of culinary Pleurotus ostreatus and P. cystidiosus mushrooms in healthy volunteers and type 2 diabetic patients on diet control and the possible mechanisms of action. Phytother. Res., 29, 303–309.
  • Jesenak, M., Urbancek, S., Majtan, J., Banovcin, P., Hercogova, J. (2015). β-Glucan-based cream (containing pleuran isolated from Pleurotus ostreatus) in supportive treatment of mild-to-moderate atopic dermatitis. J. Derm. Treat., 10,1–4.
  • Kajaba, I., Simoncic, R., Frecerova, K., Belay, G. (2008). Clinical studies on the hypolipidemic and antioxidant effects of selected natural substances. Bratisl. Lek Listy, 109, 267–272.
  • Kaneto, H., Katakami, N., Matsuhisa, M., Matsuoka, T. (2010). Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediat. Inflamm., ID 453892, doi: 10.1155/2010/453892.
  • Karácsonyi, Š., Kuniakb, Ľ. (1994). Polysaccharides of Pleurotus ostreatus: Isolation and structure of pleuran, an alkali-insoluble β-d-glucan. Carbohydr. Polym., 24, 107–111.
  • Kavalipati, N., Shah, J., Ramakrishan, A., Vasnawala, H. (2015). Pleiotropic effects of statins. Indian J. Endocrinol. Metab., 19, 554–562.
  • Khatun, K., Mahtab, H., Khanam, P.A., Sayeed, M.A., Khan, K.A. (2007). Oyster mushroom reduced blood glucose and cholesterol in diabetic subjects. Mymens. Med. J., 16, 94–99.
  • Kholoud, M.A., Nahla, A.B., Nadia, S., Al., K. (2014). Cultivation of oyster mushroom Plerotus ostreatus on date-palm leaves mixed with other agro-wastes in Saudi Arabia. Saudi J. Biol. Sci., 21, 616–625.
  • Kim, M.Y., Seguin, P., Ahn, J.K., Kim, J.J., Chun, S.C., Kim, E.H., Seo, S.H., Kang, E.Y., Kim, S.L., Park, Y.J., Ro, H.M., Chung, I.M. (2008). Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from Korea. J. Agric. Food Chem., 56, 7265–7270.
  • Krupodorova, T., Rybalko S., Barshteyn, V. (2014). Antiviral activity of Basidiomycete mycelia against influenza type A (serotype H1N1) and herpes simplex virus type 2 in cell culture. Virol Sin., 29, 284–290.
  • Maiti, S., Mallick, S.K., Bhutia, S.K., Behera, B., Mandal, M., Maiti, T.K. (2011). Antitumor effect of culinarymedicinal oyster mushroom, Pleurotus ostreatus (Jacq.: Fr.) P. Kumm., derived protein fraction on tumorbearing mice models. Int. J. Med. Mushrooms, 13, 427–440.
  • Meetoo, D., McGovern, P., Safadi, R. (2007). An epidemiological overview of diabetes across the world. Br. J. Nurs., 16, 1002–1007.
  • Meza-Menchaca, T., Suárez-Medellín, J., Del Ángel-Piña, C., Trigos, Á. (2015). The amoebicidal effect of ergosterol peroxide isolated from Pleurotus ostreatus. Phytother. Res., 29, 1982–1986.
  • Mohamed, E.M., Farghaly, F.A. (2014). Bioactive compounds of fresh and dried Pleurotus ostreatus mushroom. Int. J. Biotech. Well. Indus., 3, 4–14.
  • Muszyńska, B., Komendacki, P., Kała, K., Opoka, W. (2014). L-Tryptophan and its derivatives in edible mushrooms species. Med. Inter. Rev., 103, 82–86.
  • Muszyńska, B., Zając, M., Kała, K., Opoka, W., Rojowski, J. (2016). Thermal processing can affect zinc availability in some edible mushrooms. LWT – Food Sci. Technol., 69, 424–429.
  • Muszyńska, B., Sułkowska-Ziaja, K., Ekiert, H. (2011). Indole compounds in some culinary – medicinal higher basidiomycetes from Poland. Int. J. Med. Mushrooms, 13, 449–454.
  • Muszyńska, B., Sułkowska-Ziaja, K., Ekiert, H. (2013). Phenolic acids in selected edible basidio-mycota species: Armillaria mellea, Boletus badius, Boletus edulis, Cantharellus cibarius, Lactarius deliciosus and Pleurotus ostreatus. Acta Sci. Pol. Hortorum Cultus, 12, 107–116.
  • Naguib, Y.M., Azmy, R.M., Samaka, R.M., Salem, M.F. (2014). Pleurotus ostreatus opposes mitochondrial dysfunction and oxidative stress in acetaminophen-induced hepato-renal injury. BMC Complement. Altern. Med., 14, 494.
  • Nesto, R.W. (2008). LDL cholesterol lowering in type 2 diabetes: What is the optimum approach? Clin. Diab., 26, 8–13.
  • Noormagi, A., Gavrilova, J., Smirnova, J., Tougu, V., Palumaa, P. (2010). Zn(II) ions co-secreted with insulin suppress inherent amyloidogenic properties of monomeric insulin. Biochem. J., 430, 511–518.
  • Palacios, I., Lozano, M., Moro, C., D’Arrigo, M., Rostagno, M.A., Martínez, J.A., García-Lafuente, A., Guillamón, E., Villares, A. (2011). Antioxidant properties of phenolic compounds occurring in edible mushrooms Food Chem., 128, 674–678.
  • Patel, S., Goyal, A. (2012). Recent developments in mushrooms as anti-cancer therapeutics: a review. Biotech, 2, 1–15.
  • Powell, S.R. (2000). The antioxidant properties of zinc. J. Nutr., 130, 1447–1454. Ramos-Ligonio, A., López-Monteon, A., Trigos, A. (2012). Trypanocidal activity of ergosterol peroxide from Pleurotus ostreatus. Phytother. Res., 26, 938– 943.
  • Ravi, B., Renitta, R.E., Prabha, M.L., Issac, R., Naidu, S. (2013). Evaluation of antidiabetic potential of oyster mushroom (Pleurotus ostreatus) in alloxan-induced diabetic mice. Immunopharm. Immunotoxic., 35, 101–109.
  • Sanches, C. (2010). Cultivation of Pleurotus ostreatus and other edible mushrooms. Appl. Microbial. Biotechnol., 85, 1321–13377.
  • Santoyo, S., Ramírez-Anguiano, A.C., Aldars-García, L., Reglero, G., Soler-Rivas, C. (2012). Antiviral activities of Boletus edulis, Pleurotus ostreatus and Lentinus edodes extracts and polysaccharide fractions against Herpes simplex virus type 1. J. Food Nutr. Res., 51, 225–235.
  • Sarangi, I., Ghosh, D., Bhutia, S.K., Mallick, S.K., Maiti, T.K. (2006). Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans. Int. Immunopharm., 6, 1287–1297.
  • Sato, M., Tokuji, Y., Yoneyama, S., Fujii-Akiyama, K., Kinoshita, M., Ohnishi, M. (2011). Profiling of hepatic gene expression of mice fed with edible japanese mushrooms by DNA microarray analysis: comparison among Pleurotus ostreatus, Grifola frondosa, and Hypsizigus marmoreus. J. Agric. Food Chem., 59, 10723– 10731.
  • Shin-Yu, C., Kung-Jui, H., Yun-Jung, H., Li-Ting, W., Jeng-Leun, M. (2012). Contents of lovastatin, g-aminobutyric acid and ergothioneine in mushroom fruiting bodies and mycelia. Food Sci. Technol-Leb., 47, 274–278.
  • Siegel, R.L., Miller, K.D., Jemal, A. (2015). Cancer statistics, 2015. CA Can. J. Clin., 65, 5–29.
  • Silva, S., Martins, S., Karmali, A., Rosa, E. (2012). Production, purification and characterisation of polysaccharides from Pleurotus ostreatus with antitumour activity. J. Sci. Food Agric., 92, 1826–1832.
  • Tahrani, A.A., Barnett, A.H. (2010). Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes. Diab. Ther., 1, 45–56.
  • Wanga, H., Gaoa, J., Ng, T.B. (2000 a). A new lectin with highly potent antihepatoma and antisarcoma activities from the oyster mushroom Pleurotus ostreatus. Biochem. Biophys. Res. Comm., 276, 587–593.
  • Wanga, H.X., Ng, T.B. (2000 b). Isolation of a novel ubiquitin-like protein from Pleurotus ostreatus mushroom with anti-human immunodeficiency virus, translationinhibitory, and ribonuclease activities. Biochem. Biophys. Res. Comm., 276, 587–593.
  • Wojewoda, W. (2003). Checklist of Polish Larger Basidiomycetes. W. Szafer Institute of Botany, Polish Acad. of Sci. Kraków.
  • Woldegiorgis, A.Z., Abate, D., Haki, G.D., Ziegler, G.R. (2014). Antioxidant property of edible mushrooms collected from Ethiopia. Food Chem., 157, 30–36.
  • Wu, J.Y., Chen, C.H., Chang, W.H., Chung, K.T., Liu, Y.W., Lu, F.J. Chen, C.H. (2011). Anti-cancer effects of protein extracts from Calvatia lilacina, Pleurotus ostreatus and Volvariella volvacea. Evid. Based Compl. Alternat. Med., ID 982368, 10 p.
  • Yim, H.S., Chye, F.Y., Tan, C.T., Ng, Y.C., Ho, C.W. (2010). Antioxidant activities and total phenolic content of aqueous extract of Pleurotus ostreatus (cultivated oyster mushroom). Mal. J. Nutr., 16, 281–291.
  • Younis, A.M., Wu, F.S., El Shikh, H.H., (2015). Antimicrobial activity of extracts of the oyster culinary medicinal mushroom Pleurotus ostreatus (higher basidiomycetes) and identification of a new antimicrobial compound. Int. J. Med. Mushrooms, 17, 579–590.
  • (2013). Antioxidant properties in the oyster mushrooms (Pleurotus spp.) and split gill mushroom (Schizophyllum commune) ethanolic extracts. Mycosphere, 4, 661–673.
  • Arora, S., Tandon, S. (2015). Mushroom extracts induce human colon cancer cell (COLO-205) death by triggering the mitochondrial apoptosis pathway and Go/G1-Phase cell cycle arrest. Arch. Iran. Med., 18, 284–295.
  • Barros, L., Baptista, P., Correia, D.M., Casal, S., Oliveira, B., Ferreira, I.C.F.R. (2007). Fatty acid and sugar compositions, and nutritional value of five wild edible mushrooms from Northeast Portugal. Food Chem., 105, 140–145.
  • Beltran-Garcia, M.J., Estarron-Espinosa, M., Ogura T. (1997). Volatile compounds secreted by the oyster mushroom (Pleurotus ostreatus) and their antibacterial activities. J. Agric. Food Chem., 45, 4049–4052.
  • Bobek, P., Galbavý, S. (1999). Hypocholesterolemic and antiatherogenic effect of oyster mushroom (Pleurotus ostreatus) in rabbits. Nahrung, 43, 339–342.
  • Bobek, P., Hromadová, M., Ozdín, L. (1995). Oyster mushroom (Pleurotus ostreatus) reduces the activity of 3-hydroxy-3-methylglutaryl CoA reductase in rat liver microsomes. Experientia, 51, 589–591.
  • Bobek, P., Ozdín, L., Galbavý, S. (1998). Dose- and timedependent hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in rats. Nutrition, 14, 282– 286.
  • Bobek, P., Ozdín, L., Kuniak, L. (1996). Effect of oyster mushroom (Pleurotus ostreatus) and its ethanolic extract in diet on absorption and turnover of cholesterol in hypercholesterolemic rat. Nahrung, 40, 222–224.
  • Cao, X.Y., Liu, J.L., Yang, W., Hou, X., Li, Q.J. (2015). Antitumor activity of polysaccharide extracted from Pleurotus ostreatus mycelia against gastric cancer in vitro and in vivo. Mol. Med. Rep., 12, 2383–2389.
  • Caz, V., Gil-Ramírez, A., Largo, C., Tabernero, M., Santamaría, M., Martín-Hernández, R., Marín, F.R., Reglero, G., Soler-Rivas, C. (2015). Modulation of cholesterol-related gene expression by dietary fiber fractions from edible mushrooms. J. Agric. Food. Chem., 63, 7371–7380.
  • Cheah, I.K., Halliwell, B. (2012). Ergothioneine; antioxidant potential, physiological function and role in disease. Biochim. Biophys. Acta. Mol. Basis Dis., 1822, 784–793.
  • Chorváthová, V., Bobek, P., Ginter, E., Klvanová, J. (1993). Effect of the oyster fungus on glycaemia and cholesterolaemia in rats with insulin-dependent diabetes. Physiol. Res., 42, 175–179.
  • Choudhury, M.B.K., Rahman, T., Kakon, A.J., Hoque, N., Akhtaruzzaman, M., Begum, M.M., Choudhuri, M.S.K., Hossain, M.S. (2013). Effects of Pleurotus ostreatus on blood pressure and glycemic status of hypertensive diabetic male volunteers Bangladesh. J. Med. Biochem., 6, 5–10.
  • Chowdhury, M.M.H., Kubra, K., Ahmed, S.R. (2015). Screening of antimicrobial, antioxidant properties and bioactive compounds of some edible mushrooms cultivated in Bangladesh. Ann. Clin. Microbiol. Antimicrob., 14, 8–13.
  • Devi, K.S., Behera, B., Mishra, D., Maiti, T.K. (2015). Immune augmentation and Dalton’s Lymphoma tumor inhibition by glucans/glycans isolated from the mycelia and fruit body of Pleurotus ostreatus. Int. Immunopharmacol., 25, 207–217.
  • Devi, K.S., Roy, B., Patra, P., Sahoo, B., Islam, S.S., Maiti, T.K. (2013). Characterization and lectin microarray of an immunomodulatory heteroglucan from Pleurotus ostreatus mycelia. Carbohydr. Polym., 94, 857–865.
  • Elbatrawy, E.N., Ghonimy, E.A., Alassar, M.M., Wu, F.S. (2015). Medicinal mushroom extracts possess differential antioxidant activity and cytotoxicity to cancer cells. Int. J. Med. Mushrooms, 17, 471–479.
  • El-Fakharany, E.M., Haroun, B.M., Ng, T.B., Redwan, E.R. (2010). Oyster mushroom laccase inhibits hepatitis C virus entry into peripheral blood cells and hepatoma cells. Prot. Pept. Lett., 17, 1031–1039.
  • Fričová, O., Koval’aková, M. (2013). Solid-State 13C CP MAS NMR spectroscopy as a tool for detection of (1→3, 1→6)-β-D-Glucan in products prepared from Pleurotus ostreatus. ISRN Anal. Chem., vol. 2013, Artic. ID 248164, 4 p.
  • Gąsecka, M., Mleczek, M., Siwulski, M., Niedzielski, P. (2015). Phenolic composition and antioxidant properties of Pleurotus ostreatus and Pleurotus eryngii enriched with selenium and zinc. Eur. Food Res. Technol., 226, 737–743.
  • Gunde-Cimerman, N., Cimerman, A. (1995). Pleurotus fruiting bodies contain the inhibitor of 3-hydroxy-3 methylglutaryl-coenzyme a reductase-lovastatin. Exp. Mycol., 19, 1–6.
  • Hajhashemi, V., Vaseghi, G., Pourfarzam, M., Abdollahi, A. (2010). Are antioxidants helpful for disease prevention? Res. Pharm. Sci., 5, 1–8.
  • Jayakumar, T., Sakthivel, M., Thomas, P.A., Geraldine, P. (2006). Antioxidant activity of the oyster mushroom Pleurotus ostreatus, on CCl(4)-induced liver injury in rats. Food Chem. Toxic., 44, 1989–1996.
  • Jayakumar, T., Thomas, P.A., Isai, M., Geraldine, P. (2008). Pleurotus ostreatus, an oyster mushroom, decreases the oxidative stress induced by carbon tetrachloride in rat kidneys, heart and brain. Chem. Biol. Interact., 176, 108–120.
  • Jayakumar, T., Thomas, P.A., Isai, M., Geraldine, P. (2010). An extract of the oyster mushroom, Pleurotus ostreatus, increases catalase gene expression and reduces protein oxidation during aging in rats. Chin. J. Integr. Med., 8, 774–780.
  • Jayasuriya, W.J., Suresh, T.S., Abeytunga, D., Fernando, G.H., Wanigatunga, C.A. (2012). Oral hypoglycemic activity of culinary-medicinal mushrooms Pleurotus ostreatus and P. cystidiosus (higher basidiomycetes) in normal and alloxan-induced diabetic Wistar rats. Int. J. Med. Mushrooms, 14, 347–355.
  • Jayasuriya, W.J., Wanigatunge, C.A., Fernando, G.H., Abeytunga, D.T., Suresh, T.S. (2015). Hypoglycaemic activity of culinary Pleurotus ostreatus and P. cystidiosus mushrooms in healthy volunteers and type 2 diabetic patients on diet control and the possible mechanisms of action. Phytother. Res., 29, 303–309.
  • Jesenak, M., Urbancek, S., Majtan, J., Banovcin, P., Hercogova, J. (2015). β-Glucan-based cream (containing pleuran isolated from Pleurotus ostreatus) in supportive treatment of mild-to-moderate atopic dermatitis. J. Derm. Treat., 10,1–4.
  • Kajaba, I., Simoncic, R., Frecerova, K., Belay, G. (2008). Clinical studies on the hypolipidemic and antioxidant effects of selected natural substances. Bratisl. Lek Listy, 109, 267–272.
  • Kaneto, H., Katakami, N., Matsuhisa, M., Matsuoka, T. (2010). Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediat. Inflamm., ID 453892, doi: 10.1155/2010/453892.
  • Karácsonyi, Š., Kuniakb, Ľ. (1994). Polysaccharides of Pleurotus ostreatus: Isolation and structure of pleuran, an alkali-insoluble β-d-glucan. Carbohydr. Polym., 24, 107–111.
  • Kavalipati, N., Shah, J., Ramakrishan, A., Vasnawala, H. (2015). Pleiotropic effects of statins. Indian J. Endocrinol. Metab., 19, 554–562.
  • Khatun, K., Mahtab, H., Khanam, P.A., Sayeed, M.A., Khan, K.A. (2007). Oyster mushroom reduced blood glucose and cholesterol in diabetic subjects. Mymens. Med. J., 16, 94–99.
  • Kholoud, M.A., Nahla, A.B., Nadia, S., Al., K. (2014). Cultivation of oyster mushroom Plerotus ostreatus on date-palm leaves mixed with other agro-wastes in Saudi Arabia. Saudi J. Biol. Sci., 21, 616–625.
  • Kim, M.Y., Seguin, P., Ahn, J.K., Kim, J.J., Chun, S.C., Kim, E.H., Seo, S.H., Kang, E.Y., Kim, S.L., Park, Y.J., Ro, H.M., Chung, I.M. (2008). Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from Korea. J. Agric. Food Chem., 56, 7265–7270.
  • Krupodorova, T., Rybalko S., Barshteyn, V. (2014). Antiviral activity of Basidiomycete mycelia against influenza type A (serotype H1N1) and herpes simplex virus type 2 in cell culture. Virol Sin., 29, 284–290.
  • Maiti, S., Mallick, S.K., Bhutia, S.K., Behera, B., Mandal, M., Maiti, T.K. (2011). Antitumor effect of culinarymedicinal oyster mushroom, Pleurotus ostreatus (Jacq.: Fr.) P. Kumm., derived protein fraction on tumorbearing mice models. Int. J. Med. Mushrooms, 13, 427–440.
  • Meetoo, D., McGovern, P., Safadi, R. (2007). An epidemiological overview of diabetes across the world. Br. J. Nurs., 16, 1002–1007.
  • Meza-Menchaca, T., Suárez-Medellín, J., Del Ángel-Piña, C., Trigos, Á. (2015). The amoebicidal effect of ergosterol peroxide isolated from Pleurotus ostreatus. Phytother. Res., 29, 1982–1986.
  • Mohamed, E.M., Farghaly, F.A. (2014). Bioactive compounds of fresh and dried Pleurotus ostreatus mushroom. Int. J. Biotech. Well. Indus., 3, 4–14.
  • Muszyńska, B., Komendacki, P., Kała, K., Opoka, W. (2014). L-Tryptophan and its derivatives in edible mushrooms species. Med. Inter. Rev., 103, 82–86.
  • Muszyńska, B., Zając, M., Kała, K., Opoka, W., Rojowski, J. (2016). Thermal processing can affect zinc availability in some edible mushrooms. LWT – Food Sci. Technol., 69, 424–429.
  • Muszyńska, B., Sułkowska-Ziaja, K., Ekiert, H. (2011). Indole compounds in some culinary – medicinal higher basidiomycetes from Poland. Int. J. Med. Mushrooms, 13, 449–454.
  • Muszyńska, B., Sułkowska-Ziaja, K., Ekiert, H. (2013). Phenolic acids in selected edible basidio-mycota species: Armillaria mellea, Boletus badius, Boletus edulis, Cantharellus cibarius, Lactarius deliciosus and Pleurotus ostreatus. Acta Sci. Pol. Hortorum Cultus, 12, 107–116.
  • Naguib, Y.M., Azmy, R.M., Samaka, R.M., Salem, M.F. (2014). Pleurotus ostreatus opposes mitochondrial dysfunction and oxidative stress in acetaminophen-induced hepato-renal injury. BMC Complement. Altern. Med., 14, 494.
  • Nesto, R.W. (2008). LDL cholesterol lowering in type 2 diabetes: What is the optimum approach? Clin. Diab., 26, 8–13.
  • Noormagi, A., Gavrilova, J., Smirnova, J., Tougu, V., Palumaa, P. (2010). Zn(II) ions co-secreted with insulin suppress inherent amyloidogenic properties of monomeric insulin. Biochem. J., 430, 511–518.
  • Palacios, I., Lozano, M., Moro, C., D’Arrigo, M., Rostagno, M.A., Martínez, J.A., García-Lafuente, A., Guillamón, E., Villares, A. (2011). Antioxidant properties of phenolic compounds occurring in edible mushrooms Food Chem., 128, 674–678.
  • Patel, S., Goyal, A. (2012). Recent developments in mushrooms as anti-cancer therapeutics: a review. Biotech, 2, 1–15.
  • Powell, S.R. (2000). The antioxidant properties of zinc. J. Nutr., 130, 1447–1454. Ramos-Ligonio, A., López-Monteon, A., Trigos, A. (2012). Trypanocidal activity of ergosterol peroxide from Pleurotus ostreatus. Phytother. Res., 26, 938– 943.
  • Ravi, B., Renitta, R.E., Prabha, M.L., Issac, R., Naidu, S. (2013). Evaluation of antidiabetic potential of oyster mushroom (Pleurotus ostreatus) in alloxan-induced diabetic mice. Immunopharm. Immunotoxic., 35, 101–109.
  • Sanches, C. (2010). Cultivation of Pleurotus ostreatus and other edible mushrooms. Appl. Microbial. Biotechnol., 85, 1321–13377.
  • Santoyo, S., Ramírez-Anguiano, A.C., Aldars-García, L., Reglero, G., Soler-Rivas, C. (2012). Antiviral activities of Boletus edulis, Pleurotus ostreatus and Lentinus edodes extracts and polysaccharide fractions against Herpes simplex virus type 1. J. Food Nutr. Res., 51, 225–235.
  • Sarangi, I., Ghosh, D., Bhutia, S.K., Mallick, S.K., Maiti, T.K. (2006). Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans. Int. Immunopharm., 6, 1287–1297.
  • Sato, M., Tokuji, Y., Yoneyama, S., Fujii-Akiyama, K., Kinoshita, M., Ohnishi, M. (2011). Profiling of hepatic gene expression of mice fed with edible japanese mushrooms by DNA microarray analysis: comparison among Pleurotus ostreatus, Grifola frondosa, and Hypsizigus marmoreus. J. Agric. Food Chem., 59, 10723– 10731.
  • Shin-Yu, C., Kung-Jui, H., Yun-Jung, H., Li-Ting, W., Jeng-Leun, M. (2012). Contents of lovastatin, g-aminobutyric acid and ergothioneine in mushroom fruiting bodies and mycelia. Food Sci. Technol-Leb., 47, 274–278.
  • Siegel, R.L., Miller, K.D., Jemal, A. (2015). Cancer statistics, 2015. CA Can. J. Clin., 65, 5–29.
  • Silva, S., Martins, S., Karmali, A., Rosa, E. (2012). Production, purification and characterisation of polysaccharides from Pleurotus ostreatus with antitumour activity. J. Sci. Food Agric., 92, 1826–1832.
  • Tahrani, A.A., Barnett, A.H. (2010). Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes. Diab. Ther., 1, 45–56.
  • Wanga, H., Gaoa, J., Ng, T.B. (2000 a). A new lectin with highly potent antihepatoma and antisarcoma activities from the oyster mushroom Pleurotus ostreatus. Biochem. Biophys. Res. Comm., 276, 587–593.
  • Wanga, H.X., Ng, T.B. (2000 b). Isolation of a novel ubiquitin-like protein from Pleurotus ostreatus mushroom with anti-human immunodeficiency virus, translationinhibitory, and ribonuclease activities. Biochem. Biophys. Res. Comm., 276, 587–593.
  • Wojewoda, W. (2003). Checklist of Polish Larger Basidiomycetes. W. Szafer Institute of Botany, Polish Acad. of Sci. Kraków.
  • Woldegiorgis, A.Z., Abate, D., Haki, G.D., Ziegler, G.R. (2014). Antioxidant property of edible mushrooms collected from Ethiopia. Food Chem., 157, 30–36.
  • Wu, J.Y., Chen, C.H., Chang, W.H., Chung, K.T., Liu, Y.W., Lu, F.J. Chen, C.H. (2011). Anti-cancer effects of protein extracts from Calvatia lilacina, Pleurotus ostreatus and Volvariella volvacea. Evid. Based Compl. Alternat. Med., ID 982368, 10 p.
  • Yim, H.S., Chye, F.Y., Tan, C.T., Ng, Y.C., Ho, C.W. (2010). Antioxidant activities and total phenolic content of aqueous extract of Pleurotus ostreatus (cultivated oyster mushroom). Mal. J. Nutr., 16, 281–291.
  • Younis, A.M., Wu, F.S., El Shikh, H.H., (2015). Antimicrobial activity of extracts of the oyster culinary medicinal mushroom Pleurotus ostreatus (higher basidiomycetes) and identification of a new antimicrobial compound. Int. J. Med. Mushrooms, 17, 579–590.
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.agro-ca1c0c45-cdab-4a7a-9f08-2038696932c6
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.